Stereotactic radiation therapy (SRT) is a method used to deliver a curative dose of external beam radiation therapy. With rapid dose drop-off and precision radiation targeting, this treatment enables for very high doses of radiation to be given without increasing the toxicity to adjacent normal tissues. By altering DNA, this treatment destroys cancer cells or slows their proliferation. The market is expected to be further fueled by elements including government initiatives, rising investments in the veterinary healthcare sector, and quickening technology breakthroughs in noninvasive SRS systems.
